QuickView for 4-(3',5'-Dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (compound)

1. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias.
2. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cel…
3. Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
4. Thrombin induces expression of cytokine-induced SH2 protein (CIS) in rat brain astrocytes: involveme…
5. Tyrosine kinase inhibitors: a new approach for asthma.

There were no clinical trials for 4-(3',5'-Dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline